EverQuote (NASDAQ:EVER – Get Free Report) is projected to announce its Q4 2025 results after the market closes on Monday, February 23rd. Analysts expect EverQuote to post earnings of $0.35 per share and revenue of $176.8210 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Monday, February 23, 2026 at 4:30 PM ET.
EverQuote Trading Up 7.5%
Shares of EVER stock opened at $15.49 on Friday. EverQuote has a twelve month low of $13.93 and a twelve month high of $30.03. The stock has a fifty day simple moving average of $22.77 and a two-hundred day simple moving average of $23.37. The stock has a market capitalization of $557.02 million, a price-to-earnings ratio of 10.83 and a beta of 0.50.
Insiders Place Their Bets
In other news, CEO Jayme Mendal sold 14,360 shares of the business’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $24.15, for a total transaction of $346,794.00. Following the sale, the chief executive officer owned 406,404 shares in the company, valued at approximately $9,814,656.60. The trade was a 3.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John L. Shields sold 2,000 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $25.73, for a total transaction of $51,460.00. Following the transaction, the director owned 25,219 shares in the company, valued at approximately $648,884.87. This trade represents a 7.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 43,768 shares of company stock valued at $1,122,957 in the last 90 days. Corporate insiders own 25.52% of the company’s stock.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several brokerages have issued reports on EVER. Zacks Research upgraded shares of EverQuote from a “hold” rating to a “strong-buy” rating in a report on Tuesday, November 4th. Wall Street Zen lowered shares of EverQuote from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 1st. Weiss Ratings reissued a “hold (c)” rating on shares of EverQuote in a research note on Thursday, January 22nd. Needham & Company LLC upped their target price on EverQuote from $38.00 to $40.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Finally, JPMorgan Chase & Co. lifted their price target on EverQuote from $30.00 to $32.00 and gave the company an “overweight” rating in a report on Friday, December 12th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, EverQuote has an average rating of “Buy” and an average target price of $30.00.
View Our Latest Stock Report on EverQuote
About EverQuote
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
Featured Stories
- Five stocks we like better than EverQuote
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
